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Summary
Objective: To investigate whether the absence of biglycan and ﬁbromodulin, two proteoglycans expressed in cartilage, bone and tendon,
resulted in accelerated osteoarthritis in the temporomandibular joint (TMJ).
Methods: Histological sections of TMJ from 3-, 6-, 9- and 18-month-old wild-type (WT) and biglycan/ﬁbromodulin double-deﬁcient (DKO) mice
were compared. Immunostainings for biglycan, ﬁbromodulin and proliferating cell nuclear antigen (PCNA) were performed.
Results: Biglycan and ﬁbromodulin were highly expressed in the disc and articular cartilage of the TMJ. At 3 months of age, both WT and DKO
presented early signs of cartilage degeneration visible as small acellular areas under the articular surfaces and superﬁcial waving. From 6
months of age, DKOs developed accelerated osteoarthritis compared to WT. At 6 months, small vertical clefts in the condylar cartilage and
partial disruption of the disk were visible in the DKO. In addition, chondrocytes had lost their regular columnar organization to form clusters. At
9 months, these differences were even more pronounced. At 18 months, extended cartilage erosion was visible in DKOs when by comparison
the thickness of the articular cartilage in WT controls was basically intact. PCNA staining was stronger in 3-month-old WT TMJ ﬁbrocartilage
than in 3-month-old DKO TMJ ﬁbrocartilage suggesting that chondrocyte proliferation might be impaired in DKOs.
Conclusion: The biglycan/ﬁbromodulin double knock-out mouse constitutes a useful animal model to decipher the pathobiology of
osteoarthritis in the TMJ.
ª 2005 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Temporomandibular joint disorders (TMD) are comprised of
a number (over 20) of pathologic conditions. Whether some
of these conditions are part of the natural history of the
same pathological process or each condition exists as
a separate entity is unknown. One of the most prevalent
conditions of TMD is osteoarthritis of the temporomandi-
bular joint (TMJ OA)1,2. Currently, there are no biomarkers
or treatments for TMJ OA. Hence, diagnosis of TMJ OA is
made by imaging techniques only after there is irreversible
damage to the joint. Due to the limited capacity of joints to
regenerate, it would be beneﬁcial if one could detect and
treat TMJ OA at an early stage. Since it is practically
impossible to obtain human pre-osteoarthritic TMJ samples,
the generation of animal models, covering the whole
disease process is necessary.
The TMJ is composed of two bones, the mandibular
condyle and the glenoid fossa of the temporal bone,
separated by a ﬁbrocartilaginous disc, the TMJ disc. Unlike
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Received 10 November 2004; revision accepted 18 April 2005.8most diarthrodial joints in which the articular surfaces are
covered by pure hyaline cartilage, the articulating surfaces
of the bones are made of ﬁbrocartilage3. Interspersed
among these tissues are members of the small leucine
repeat proteoglycan (SLRP) family. Members of this family
are characterized by a small protein core that consists
predominantly of the repetition of leucine-rich regions4. Four
of them, biglycan (Bgn), ﬁbromodulin (Fmod), lumican and
decorin are found in bone, cartilage and tendons, have
been shown to be able to bind transforming growth factor
(TGF)-beta and play a role in regulating collagen ﬁbrillo-
genesis (see Ameye and Young5 for a review).
We have previously shown that mice double deﬁcient in
Bgn and Fmod have severe and premature knee OA, while
mice single deﬁcient in Bgn or Fmod have a milder form of
it6. Mice single deﬁcient in lumican and mice double
deﬁcient in lumican and ﬁbromodulin have also been shown
to develop premature knee OA but again more slowly than
the mice double deﬁcient in Bgn and Fmod7. Mice single
deﬁcient in decorin, in contrast to mice single deﬁcient in
Bgn, Fmod or lumican, do not develop OA. We have
previously shown that knees from mice double deﬁcient in
Bgn and Fmod displayed a progressive degeneration of the
articular cartilage from early ﬁbrillation to complete erosion,
subchondral sclerosis, osteophytes and bone cysts, the
hallmarks of human OA6. In this study, we investigated17
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accelerated TMJ OA. We chose to use the Bgn/Fmod
double-deﬁcient mouse instead of the other SLRP deﬁcient
mice not only because they were available to us, but also
because the more rapid progression of the disease in this
mouse makes it a more convenient animal model to study.
We found by histology, that mice that were deﬁcient in both
Bgn and Fmod have accelerated OA in their TMJ compared
to control mice. We also characterized mandibular condylar
cartilage proliferation and found that the double-deﬁcient
mice had a signiﬁcant decrease in condylar chondrocyte
proliferation compared to WT before TMJ OA was overt.
Methods and materials
GENERATION OF Bgn AND Fmod SINGLE
AND DOUBLE-DEFICIENT MICE
All experiments were performed under an institutionally
approved protocol for the use of animals in research
(#NIDCR-IRP-98-058 and 01-151). Mice deﬁcient in Bgn
or Fmod were generated by gene targeting in embryonic
stem cells as described previously6. Heterozygous Bgn/
Fmod-deﬁcient mice were produced by breeding a homozy-
gous Bgn-deﬁcient female (Bgn//FmodC/C) with an
Fmod-deﬁcient male (BgnC/0/Fmod/); Bgn males are
designed as Bgn/0 since the Bgn gene is located on the X
chromosome and absent from the Y chromosome. F2 Bgn/
Fmod double-deﬁcient (male Bgn/0/Fmod/ and female
Bgn//Fmod/) mice were obtained by interbreeding F1
heterozygous Bgn/Fmod mice and will be referred to
hereafter as Bgn/Fmod DKO mice.
GENOTYPING
All mice were genotyped for Bgn and Fmod alleles by
polymerase chain reaction (PCR) analysis as described
previously6. PCR products were resolved by electrophore-
sis through 1.8% agarose gels, yielding bands of 212 bp for
the WT Bgn allele, 310 bp for the disrupted Bgn allele,
280 bp for the WT Fmod allele, and 603 bp for the disrupted
Fmod allele.
HISTOLOGY AND IMMUNOHISTOCHEMISTRY
For each genotype and age, heads from at least three
animals were dissected in two halves. After removal of the
brain, the specimens were ﬁxed for 2 weeks at room
temperature in 10% formalin. After being washed in tap
water for 5 min, they were decalciﬁed in formic acid bone
decalciﬁer solution (Immunocal from Decal Corporation,
Tallman, NY, USA) for 4 weeks. Specimens were then
washed in tap water for 5 min and ﬁxed for 3 days in
buffered zinc formalin (Z-ﬁx from Anatech Ltd, Battle Creek,
MI, USA) before being classically processed for histology
and sectioned sagittally. Sections were stained by hema-
toxylin and eosin (H&E) or by Safranin O8.
Tissue sections were deparafﬁnized with xylene. Follow-
ing rehydration, with graded ethanol, endogenous peroxi-
dase activity was blocked by treating the sections in 3%
peroxide in methanol for 20 min. In order to expose the
antigen, sections were predigested in chondroitinase ABC
(cat# KE01502, Seikagaku Corp, Tokyo, Japan) at a con-
centration of 0.015 units/ml for 1 h at 37(C. Non-speciﬁc
binding was reduced by incubating the sections in 10% goat
serum for 30 min. Sections were then incubated for 1 h
at 37(C with primary antibody at a 1: 200 dilution.Fibromodulin and biglycan antibodies (LF 150 and LF
106, respectively) were kind gifts from Larry Fisher9,
whereas proliferating cell nuclear antigen (PCNA) antibody
clone PC 10 was purchased from DAKO Cytomation
(Carpinteria, CA, USA). Biotinylated goat anti-rabbit second-
ary antibody was used and visualized by a streptavidine
peroxidase solution in presence of AEC chromagen.
The data presented in this paper were reproduced in at
least three different animals of the same genotype at each
age. Serial sections through the whole joints were obtained
for each animal and observations were conﬁrmed in
different interspaced serial sections chosen to cover the
whole joint. In this way, it was ensured that the reported
observations were genuine and not local random abnor-
malities. In order to minimize experimental variability, WT
and DKO were processed in parallel at the same time for
histology and immunohistostainings.
EVALUATION OF PCNA STAINING
Images from sections immunostained with PCNA were
captured using an AxioCam MR camera (Zeiss). A
rectangular box was constructed to evaluate the percentage
of PCNA positive cells in the mandibular condylar cartilage.
The number of PCNA positive cells were counted and
divided by the total number of cells within the box. For each
section, three areas were analyzed, corresponding to
anterior, center and posterior portions of the mandibular
condylar cartilage. Eleven sections from three different
3-month-old DKO mice and 10 sections from three different
3-month-old WT mice were evaluated.
Results
Immunohistochemistry revealed that Bgn and Fmod were
abundantly expressed within the TMJ of 3-month-old WT
mice (Fig. 1). Both were found in the disc, and in the
articular cartilage of the mandibular condyle. In the disc,
ﬁbromodulin was found in the anterior and posterior
attachment parts, while biglycan was found predominantly
in the anterior attachment portion of the disk. Regarding
their expression in the articular cartilages of the glenoid
fossa and the mandibular condyle, both proteoglycans were
more highly expressed in the anterior and posterior parts of
these cartilages than in the central parts [Fig. 1(a and b)]. At
the same time, they were also more highly expressed in the
superﬁcial zone than in the deeper zones. This pattern of
differential expression was more marked for Bgn than for
Fmod: Bgn was not expressed in the central parts and in the
deepest zones of these articular cartilages, while Fmod was
expressed although at a relatively low level [Fig. 1(c and d)].
As the mice aged, the localization of Bgn and Fmod
remained the same; however, there was an overall de-
crease in the intensity of their immunohistochemical
staining (data not shown).
In order to examine the function of Bgn and Fmod in the
TMJ, the morphology of TMJ from WT and double-deﬁcient
mice was compared at 3, 6, 9 and 18 months of age. At 3
months, early and similar signs of degeneration were
present in the articular cartilage of the mandibular condyle
from deﬁcient and WT TMJs. These defects consisted of
the presence of small acellular areas under the articular
surfaces and superﬁcial waving (Fig. 2). While little differ-
ences were apparent at 3 months of age between the WT
and deﬁcient TMJs, they became obvious at 6 months of
age due to the accelerated degeneration of the articular
819Osteoarthritis and Cartilage Vol. 13, No. 9Fig. 1. (a) Immunohistochemistry of ﬁbromodulin (Fmod) performed on sagittal sections of the TMJ area of WT 3-month-old mice;
5! magniﬁcation. (b) Immunohistochemistry of biglycan (Bgn) performed on the sagittal sections of the TMJ area from 3-month-old WT mice;
5! magniﬁcation. (c) 20! magniﬁcation of boxed area shown in panel a. (d) 20! magniﬁcation of boxed area shown in panel b.
(e and f). Negative controls picturing immunohistostaining of Fmod (e) and Bgn (f) on sagittal sections of the TMJ area from 3-month-old
Bgn/Fmod DKO mice.cartilages in the deﬁcient TMJ. At this age in the Bgn/Fmod
DKO, partial disruption of the disk was sometimes observed
while in the articular cartilage of the condyle, small vertical
clefts were visible and chondrocytes started to lose their
regular columnar organization and form clusters [Fig. 3(d)].
At 9 months, the vertical clefts and chondrocyte clusters
became more severe in the condylar cartilage of the Bgn/
Fmod DKO mice, while in the WT there was no evidence of
either of these two characteristics (Fig. 4). Moreover, while
quite extensive acellular areas were present in the deﬁcient
articular cartilage, such areas remained small in the WT
articular cartilage [see Fig. 4(c and d), for comparison]. By
18 months, there was almost complete destruction of thearticular cartilage of the condyle in the DKO mice [Fig. 5(b,
d and f)]. The erosion on the articular surface of the condyle
was so extended that it resulted in a signiﬁcant decrease in
cartilage thickness [see Fig. 5(aeb and eef) for compari-
son]. In addition, the chondrocytes had completely lost their
vertical columnar organization. Finally, partial disruption of
the disc was often observed [Fig. 5(b and d)]. In contrast, in
the WT, the articular cartilage displayed some small clefts,
but retained more or less the normal columnar chondrocyte
organization [Fig. 5(a, c and e)].
In parallel to the articular cartilage degeneration,
osteophyte formation was observed in the double-deﬁcient
mice [Fig. 6(b and d)] but not in the WT [Fig. 6(a and c)].
820 S. Wadhwa et al.: Bgn/Fmod deﬁcient mice have TMJ OAFig. 2. Sections of the TMJ from 3-month-old WT (a, c and e) or Bgn/Fmod DKO mice (b, d and f) stained with hematoxylin and eosin (H&E).
The asterisk shows the small acellular areas under the articular surfaces. Note the waving of the articular cartilage surface in (def).Osteophytes started to form on the mandibular condyle
and the glenoid fossa of the temporal bone from 6 months
of age. They were well developed by 18 months of age,
particularly on the posterior side of the condyle [Fig. 6(b
or d)]. High inter-individual variability in the thickness of
the subchondral bone did not allow us to determine
whether or not subchondral sclerosis was more pro-
nounced or even present in the double-deﬁcient mice
compared to the WT.
To further characterize the development of TMJ OA in the
double-deﬁcient mice compared to WT, TMJ sections werestained with Safranin O. Safranin O is a cationic dye that
binds to the negatively charged glycosaminoglycans. At 18
months in the DKO mice but not in the WT, some of the
ﬁbrocartilaginous cells of the temporomandibular disc
changed phenotype and started to synthesize glycosami-
noglycans as suggested by their pericellular staining with
Safranin O [Fig. 6(f)].
We next examined if we could identify any defects in
cellular proliferation in the condylar articular cartilage of the
double-deﬁcient mice. Immunohistochemistry against
PCNA (a measure of proliferation) revealed that there was
821Osteoarthritis and Cartilage Vol. 13, No. 9Fig. 3. Sections of the TMJ from 6-month-old WT (a and c) or Bgn/Fmod DKO mice (b and d) stained with hematoxylin and eosin (H&E). The
arrowhead points to small vertical clefts, the asterisks show the small acellular areas under the articular surfaces and the arrow shows regions
where chondrocytes lose their regular columnar organization and form clusters.a signiﬁcant decrease in the number of positive cells in the
condylar cartilage of 3-month-old DKO compared to WT
[Fig. 7(d)]. This decrease in proliferation occurred before the
double-deﬁcient mice showed any histological evidence of
accelerated TMJ OA. However, once the double-deﬁcient
mice had developed signs of accelerated TMJ OA (6-month-
old), PCNA staining revealed a high number of positive cells
in the chondrocyte clusters of their condylar cartilage
[Fig. 7(f)].
Discussion
The majority of animal models for TMJ OA involve
chemical or physical trauma to the joint. They include the
local application of Freud’s adjuvant10, the application of
carrageenan11, forced bite opening12 and surgical manip-
ulation of the TMJ structures13e16. Unlike traumatic models
of TMJ OA, genetically modiﬁed animal models provide
information on why certain populations are more likely to
develop the disease. Because both genetic and environ-
mental factors may be precisely deﬁned and controlled,
genetic mouse models hold the potential to reveal the
molecular pathways that inﬂuence the degeneration of the
TMJ. Besides our model, there are four other reported
genetic mouse models of TMJ OA17e20. Two of the modelshave collagen mutations: the transgenic Del1 mouse, which
has mutations in the Col2a1 gene, and the transgenic cho
mouse, which has a mutation in the alpha1 chain of type
collagen XI gene19,20. The fourth genetic model is the
Institute for Cancer Research mouse strain whose genetic
etiology for the development of OA is unknown. Thus, animal
models with alterations in Bgn, Fmod, TNF-alpha, collagen
type II and collagen type XI expression develop TMJ OA.
This suggests that TMJ OA could be a genetically inherited
disease although twin studies argue against this hypothesis
by showing no difference in the prevalence of TMJ disorders
between monozygotic twins and dizygotic twins21,22.
In the articular hyaline cartilage, OA increases the
expression levels of Bgn and Fmod23e25 whereas in the
meniscal ﬁbrocartilage, OA increases Bgn expression, but
decreases Fmod expression26. Therefore, OA seems to
affect Fmod expression differently depending on the type of
cartilage. In the TMJ speciﬁcally, Bgn had been shown to be
expressed in the disk and in the ﬁbrocartilage of the
mandibular condyle27e29 but this is the ﬁrst report, that
we are aware of, describing the expression of Fmod in
the TMJ.
We have previously shown that mice double deﬁcient in
Bgn and Fmod had severe and premature knee OA6. In this
study, we found that these mice also develop premature
TMJ OA although the osteoarthritic changes in the knee
822 S. Wadhwa et al.: Bgn/Fmod deﬁcient mice have TMJ OAFig. 4. Sections of the TMJ from 9-month-old WT (a and c) or Bgn/Fmod DKO mice (b and d) stained with hematoxylin and eosin (H&E). The
arrowheads show vertical clefts, the asterisks show the small acellular areas under the articular surfaces and the arrow shows regions where
chondrocytes lose their regular columnar organization and form clusters.occurred more rapidly than in the TMJ. In the knee, there
were no osteoarthritic lesions detected in 1-month-old
double-mutant mice. However, by 6 months, there was
almost complete erosion of the articular cartilage. In
contrast, in the TMJ at 6 months, only early histological
evidence of osteoarthritic lesions started to become visible.
In the knee, ectopic ossiﬁcation of tendons and ligaments
was detected before signiﬁcant cartilage lesions develop6.
In contrast, we did not detect any ectopic ossiﬁcation in the
TMJ although the chondrocytic-like phenotype displayed by
some ﬁbrocartilageneous cells of the disc at 18 months, as
evidenced by Safranin O staining, is reminiscent of the early
stages of formation of ectopic bones as observed in the
tendons and ligaments of knees from Bgn and Fmod
double-deﬁcient mice.
The primary purpose of this study was to investigate if the
absence of Bgn and Fmod resulted in accelerated TMJ OA.
Originally, after establishing the timing of progression of TMJ
OA in the double-deﬁcient mice, our plan was to continue
with the study of TMJ OA in the two single deﬁcient mice to
determine to which extent each single deﬁciency contributes
to the phenotype. However, we later changed our mind in
view of the slow progression of the disease in the TMJ and of
its relative mildness compared to the knee. Based on our
former knee observations in these single and double-
deﬁcient mice, it is probable that the Bgn and Fmod singledeﬁcient mice develop a very mild form of TMJ OA, similar to
the one displayed by the WT. Indeed, we have shown that
the single deﬁcient Bgn and the single deﬁcient Fmod mice
develop a milder form of knee OA than the double-deﬁcient
mice6. We were able to detect signiﬁcant differences in
a semi-quantitative grading score for knee OA at 3 months
for the Bgn-deﬁcient mice and at 9 months for the Fmod-
deﬁcient mice compared to the knee of WT mice. However,
unlike the TMJ, the knee of 9-month-old WT mice shows no
signs of OA6, a characteristic, which helped to clearly
demonstrate the presence of OA in the single deﬁcient mice.
In the presence of TMJ OA in the WT and in view of the slow
progression of TMJ OA in the double-deﬁcient mouse, it is
probable that even by 2 years of age, the difference in
severity of TMJ OA between the WT and the two single
deﬁcient mice will be too small to clearly determine to which
extent each deﬁciency contributes to the TMJ phenotype of
the double-deﬁcient mouse. Hence, we can only extrapolate
that similarly to what happens for knee OA, each deﬁciency
partially contributes to the accelerated TMJ OA detected in
the Bgn/Fmod double-deﬁcient mice.
The mechanisms by which the absence of Bgn and Fmod
accelerates the development of OA are currently unknown.
One possible mechanism is that the absence of Bgn and
Fmod would make the joint structures less suited to
withstanding mechanical loading and therefore more prone
823Osteoarthritis and Cartilage Vol. 13, No. 9Fig. 5. Sections of the TMJ from 18-month-old WT (a, c and e) Bgn/Fmod DKO (b, d and e) mice stained with hematoxylin and eosin (H&E).
The arrowheads point to the extensive destruction of the articular cartilage in the condyle of the Bgn/Fmod DKO mice. Asterisks show acellular
areas. Large arrows point to large chondrocyte clusters. Thin arrow shows disc disruption.to osteoarthritic lesions. In support of this, a recent study
has shown that the viscoelastic properties of the temporo-
mandibular disc decrease with the reduction of proteogly-
can content30. Structurally weak tendons were also
suggested to cause knee OA in the Bgn/Fmod double-
deﬁcient mice because gait problems, as well as structurally
and mechanically compromised tendons, were present
before OA started to develop6. A similar mechanism could
also take place in the TMJ. Finally, it is also possible that
OA arises indirectly from changes in the underlying bone.Mice deﬁcient in Bgn have been shown to have age-
dependent osteoporosis31.
Changes in the biomechanical properties of cartilage,
tendons and bone could arise from the ability of Bgn and
Fmod to regulate collagen ﬁbrillogenesis (see Ameye and
Young5 for review). It has been shown that the distribution in
size of the collagen ﬁbrils in the quadriceps tendon of the Bgn
deﬁcient, Fmod-deﬁcient and Bgn/Fmod double deﬁcient are
different compared to the tendons from WT mice6. Alterna-
tively or additionally, changes in these tissues could also
824 S. Wadhwa et al.: Bgn/Fmod deﬁcient mice have TMJ OAFig. 6. (aeb) Eighteen-month-old Bgn/Fmod DKO mice (b) displays osteophytes (arrows) contrary to 18-month-old WT mice (a). (ced) Higher
magniﬁcation of (a) and (b), picturing the posterior part of the mandibular condyle. (eef) Safranin O staining of TMJ sections from 18-month-old
WT (e) and Bgn/Fmod DKO (f) mice. Arrows show the strong pericellular staining present around some of the cells of the disc.result from the abilities of Bgn and Fmod to modulate the
actions of members of the TGF-beta superfamily with their
receptors. On one hand, Bgn and Fmod can both bind to
members of the TGF-beta family32 and may regulate their
activity by sequestering TGF-beta family members into the
extracellular matrix32, thereby inhibiting their interactions
with their cellular receptors. On the other hand, Bgn has
been shown to improve the presentation of bone morpho-
genetic protein 4 (BMP-4) to its receptor in bone marrow
stromal cells33. Through such interactions with members ofthe TGF-beta family or with cell receptors, small leucine-rich
proteoglycans are known to participate in the regulation of
cell proliferation (see Kresse and Schonherr34, for a review).
For example, overexpression of biglycan causes an increase
in the proliferation of vascular smoothmuscle cells35 while its
deﬁciency decreases the proliferation of bone marrow
stroma cells36. Biglycan has a nuclear localization sequence
and has been found in the nuclei of neuronal cells where it
has been suggested to be involved in cell proliferation37. In
this context, we report here a decrease in chondrocyte
825Osteoarthritis and Cartilage Vol. 13, No. 9Fig. 7. Immunohistochemistry of proliferating cellular nuclear antigen (PCNA) performed on sagittal sections of the TMJ area of WT (a, c and e)
and Bgn/Fmod DKO (b and f) mice at the age of 3 months (a, b, c) or 6 months (e, f). (c) Negative control where primary PCNA antibody was
omitted on the TMJ area of 3-month-old WT mice. Arrows indicate positive PCNA staining. Panel d shows histogram representing the
percentage of PCNA positive cells in mandibular condylar cartilage from three WT (white bar) and three DKO (checkered bar) 3-month-old
mice. Three to four slides were taken from each animal. #P! 0.05.
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osteoarthritic lesions developed suggesting that the impair-
ment in chondrocyte proliferation induced by the Bgn and
Fmod deﬁciency could be a key event in the early de-
velopment of TMJ OA in this animal model.
A similar decrease in chondrocyte proliferation has been
shown in a diminished mechanical loading model of the
TMJ. In this model, the experimental group was fed a soft
diet and the incisors were shortened regularly to keep them
out of occlusion, while the controls were fed a hard diet. The
experimental group had reduced chondrocyte proliferation
after 12e24 h and it occurred before there was any
evidence of cartilage breakdown (as measured by matrix
metalloproteinase staining), which appeared only after 9
days38. Similar to what has been described in other models
of TMJ OA, there was an increase in cell proliferation
observed in the chondrocyte clusters of double-deﬁcient
condylar cartilage after there was overt OA, which may be
part of an attempted repair response13,39.
In conclusion, this report describes a new animal model
for TMJ OA and conﬁrms the important role that is played by
small leucine-rich proteoglycans in the biological homeo-
stasis of joints in general and in the pathobiology of OA in
particular. The observation that cell proliferation in the
articular cartilage is decreased at the onset of OA in the
absence of Bgn and Fmod creates exciting new opportu-
nities of investigation to further decipher the functions of
small leucine-rich proteoglycans in the biology of articular
cartilage.
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